A rare case of Epstein-Barr virus-induced Bell’s palsy in an 18-year-old highlights the need for EBV testing in sudden facial ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Several experts are seeing that value of AI's total overhaul of healthcare, including beneficial additions such as generative ...

On this "Face the Nation with Margaret Brennan" broadcast, moderated by Margaret Brennan: Sen. Mark Warner, Democrat of ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

The following is the transcript of an interview with former FDA commissioner Scott Gottlieb, Pfizer board member and ...

The Institute has a strong pedigree in understanding the fundamental mechanisms that underpin the success of vaccination and in the development of novel vaccines and their mode of action.

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

Controversy over AB Hernandez's participation in girls' sports included rule changes, federal investigations and online threats to the state of California by President Donald Trump.

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies ...